Working toward a Globally Diverse and Inclusive Community of Medicinal Chemists of the Future.
Working toward a Globally Diverse and Inclusive Community of Medicinal Chemists of the Future.
复制标题
致力于建立一个全球多元化和包容性的未来药物化学家社区。
DOI：
10.1021/acsmedchemlett.2c00533
复制
发表时间：
2023
影响因子：
4.2
通讯作者：
J. Glen
中科院分区：
文献类型：
--
作者：
M. Fisher;L. Pellerin;W. Nokleberg;N. Ratchkovski;J. Glen
ACS 药物化学快报。作为该期刊自 2010 年创刊以来的第二位 EIC，我认识到我的前任、该期刊的首任 EIC Dennis C. Liotta 教授所奠定的坚实基础。我要感谢丹尼斯多年来对期刊的领导、奉献和承诺。当我带领期刊走向未来时，我将站在丹尼斯的肩膀上。接替丹尼斯是一种巨大的荣誉和荣幸。由于需要一个团队才能获胜，或者一个村庄才能养育一个孩子，我还要感谢现任和过去的编辑、顾问和早期职业委员会成员为该杂志提供的服务。最后但并非最不重要的一点是，我要感谢《ACS 药物化学快报》上发表的各种稿件类别的所有作者的积极贡献，使该期刊成为其联盟中的领先期刊（影响因子 2021：4.632；引文 2021：9499；CiteScore 2021：6.6），这是一个在药物化学领域快速传播高质量研究的平台。我感谢《药物化学杂志》的 EIC 克雷格·林斯利 (Craig Lindsley) 给我机会担任《药物化学杂志》的副主编。从《Journal of Medicine Chemistry》的这个职位中，我获得了宝贵的经验，我将把这些经验带到 ACS 药物化学快报 EIC 的岗位上。我将编辑委员会、作者和审稿人视为一个合作伙伴网络，他们的关系建立在共同利益、共同责任、相互问责和相互尊重的基础上。我相信我们都是为了推进科学研究的利益而行动。我领导下的编辑委员会基本上将与审稿人和作者合作，以确保高质量的手稿能够快速发表。为了确保质量和尽可能高的标准，我们有责任共同确保我们所服务的社区理解药物化学的含义。在基本层面上，药物化学需要被理解为一门学科，它利用来自多个学科的所有信息和知识来设计一种分子，克服任何障碍，成为一种安全有效的药物。从整体上讲，药物化学整合了多个学科：合成化学、计算化学、理化性质、代谢和药代动力学、生物性质、专利和出版物以及安全性。尽管迄今为止药物化学一直以小分子为主，但它也包括基于肽的疗法、纳米抗体和抗体药物偶联物以及人工智能驱动的药物化学。
ACS Medicinal Chemistry Letters. As the second EIC of the journal since its launch in 2010, I am cognizant of the strong foundation laid by my predecessor and the inaugural EIC of the journal, Prof. Dennis C. Liotta. I would like to thank Dennis for his leadership, dedication, and commitment to the journal over many years. I will be standing on the shoulders of Dennis even as I lead the journal into the future. It is a tremendous honor and privilege to succeed Dennis. As it takes a team to win or a village to raise a child, I would also like to extend my thanks and appreciation to the current and past members of the editorial, advisory, and early career boards for the service given to the journal. Finally, but not least, I would like to thank all authors of the various manuscript categories published in ACS Medicinal Chemistry Letters for their positive contributions that have made the journal the leading journal in its league (Impact Factor 2021: 4.632; Citations 2021: 9499; CiteScore 2021: 6.6), a platform for rapid dissemination of high-quality research across the breadth of medicinal chemistry. I am grateful to the EIC of the Journal of Medicinal Chemistry, Craig Lindsley, for giving me the opportunity to serve in my recent role as Associate Editor with the Journal of Medicinal Chemistry. From this role at Journal ofMedicinal Chemistry, I have gained valuable experience, which I will bring to my role as EIC of ACS Medicinal Chemistry Letters. I see the editorial board, authors, and reviewers as a network of partners whose relationship is based on mutual interest, mutual responsibility, mutual accountability, and mutual respect. I believe that we are all acting in the interest of advancing scientific research. The editorial board under my leadership will essentially be in partnership with reviewers and authors to see good-quality manuscripts published quickly. To ensure quality and the highest possible standards, collectively we have a responsibility to ensure that what medicinal chemistry entails is understood by the community we serve. At a basic level, medicinal chemistry needs to be understood as a discipline that uses all information and knowledge from multiple disciplines toward enabling the design of a molecule that overcomes any hurdles to become a safe and efficacious medicine. Holistically speaking, medicinal chemistry integrates multiple disciplines: Synthetic Chemistry, Computational Chemistry, Physicochemical Properties, Metabolism and Pharmacokinetics, Biological Properties, Patents and Publications, and Safety. Although medicinal chemistry has so far been dominated by small molecules, it also includes peptide-based therapeutics, nanobodies and antibody− drug conjugates, and AI-driven medicinal chemistry.